ASTRAZENECA AB
Vastra Maelarhamnen – Sodertaelje – 151 85
VAT: SE556011748201
http://www.astrazeneca.com
Complicit EU Projects
Within the Horizon 2020 (2014-2020) framework, ASTRAZENECA AB has received € 927,500.0 for its participation in a total of 8 project(s) with a total cost of € 220,089,496.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-01 | 831458 | Trials@Home | 2024-08-31 | participant | € 0.0 | € 39,148,297 | 1 | 33 | CORDIS ↪ | |
| 2019-04-01 | 820820 | MOBILISE-D | drug discovery · multiple sclerosis · sensors · health care services · cardiology | 2024-03-31 | participant | € 0.0 | € 49,911,564 | 2 | 38 | CORDIS ↪ |
| 2021-07-01 | 101007939 | RealHOPE | proteins · pharmacology and pharmacy | 2025-06-30 | participant | € 0.0 | € 7,132,608 | 1 | 27 | CORDIS ↪ |
| 2020-01-01 | 853992 | PharmaLedger | governance · big data · cryptography · business intelligence · health care services | 2022-12-31 | participant | € 0.0 | € 22,118,324 | 2 | 30 | CORDIS ↪ |
| 2018-05-01 | 777492 | PIONEER | prostate cancer · big data | 2023-10-31 | participant | € 0.0 | € 13,549,159 | 1 | 38 | CORDIS ↪ |
| 2019-11-01 | 853966 | EU-PEARL | governance · tuberculosis | 2023-04-30 | participant | € 0.0 | € 25,938,047 | 1 | 41 | CORDIS ↪ |
| 2019-09-01 | 825828 | EXPERT | drug discovery · nanomedicine · oncology · nano-materials | 2025-02-28 | participant | € 927,500.0 | € 15,010,087 | 1 | 13 | CORDIS ↪ |
| 2017-11-01 | 777377 | LITMUS | drug discovery · diabetes · hepatology · obesity | 2023-10-31 | participant | € 0.0 | € 47,281,406 | 1 | 60 | CORDIS ↪ |
Within the Horizon Europe (2021-2027) framework, ASTRAZENECA AB has received € 520,000.0 for its participation in a total of 2 project(s) with a total cost of € 152,362,619.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-01 | 101057659 | EDITSCD | gene therapy · mutation · amines · transplantation · genomes | 2027-08-31 | participant | € 520,000.0 | € 6,532,000 | 1 | 9 | CORDIS ↪ |
| 2024-09-01 | 101156595 | ERDERA | ecosystems | 2031-08-31 | associatedPartner | € nan | € 145,830,619 | 2 | 178 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, ASTRAZENECA AB has received € 209,010.0 for its participation in a total of 10 project(s) with a total cost of € 661,784,593.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-02-01 | 115188 | PREDECT | bioreactors · lung cancer | 2016-04-30 | participant | € nan | € 21,020,760 | 1 | 21 | CORDIS ↪ |
| 2013-01-01 | 115523 | COMBACTE-NET | bacteriology · antibiotic resistance | 2021-02-28 | coordinator | € nan | € 220,954,266 | 1 | 39 | CORDIS ↪ |
| 2015-03-01 | 115620 | COMBACTE-CARE | bacteriology · epidemics prevention · antibiotics · multidrug resistance · antibiotic resistance | 2020-02-28 | participant | € nan | € 85,113,336 | 2 | 23 | CORDIS ↪ |
| 2009-06-15 | 115003 | SAFE-T | data science · databases · pathology · modeling of diseases spread | 2015-06-14 | participant | € nan | € 36,427,294 | 1 | 26 | CORDIS ↪ |
| 2008-02-01 | 201924 | EDICT | alkali metals · crystallography · proteins · electron microscopy · microbiology | 2012-06-30 | participant | € 209,010.0 | € 15,718,166 | 1 | 28 | CORDIS ↪ |
| 2011-03-01 | 115156 | DDMORE | ontology · software · public health · ecosystems · mathematical model | 2016-08-31 | participant | € nan | € 23,063,274 | 1 | 28 | CORDIS ↪ |
| 2009-09-01 | 115008 | NEWMEDS | drug discovery · cognitive neuroscience · pharmaceutical drugs · schizophrenia · machine learning | 2015-02-28 | participant | € nan | € 24,849,675 | 1 | 20 | CORDIS ↪ |
| 2012-10-01 | 115439 | STEMBANCC | neurobiology · drug discovery · diabetes · stem cells · toxicology | 2018-03-31 | participant | € nan | € 55,010,480 | 2 | 38 | CORDIS ↪ |
| 2014-10-01 | 115618 | DRIVE-AB | drug discovery · public health · databases · antibiotics · antibiotic resistance | 2017-12-31 | coordinator | € nan | € 10,968,676 | 1 | 23 | CORDIS ↪ |
| 2015-01-01 | 115737 | COMBACTE-MAGNET | epidemics prevention · critical care medicine · antibiotics · multidrug resistance · antibiotic resistance | 2021-12-31 | coordinator | € nan | € 168,658,666 | 1 | 40 | CORDIS ↪ |